JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $255,000 | -61.4% | 5,588 | -62.0% | 0.22% | -62.7% |
| Q3 2017 | $660,000 | +22.9% | 14,720 | -18.1% | 0.59% | +20.3% |
| Q2 2017 | $537,000 | +34.2% | 17,970 | -0.3% | 0.49% | +65.7% |
| Q1 2017 | $400,000 | +85.2% | 18,030 | +57.1% | 0.30% | +72.7% |
| Q4 2016 | $216,000 | +3.8% | 11,478 | +65.9% | 0.17% | +47.0% |
| Q3 2016 | $208,000 | -34.2% | 6,918 | +37.0% | 0.12% | -53.2% |
| Q2 2015 | $316,000 | – | 5,050 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |